Open AccessFirst line osimertinib for the treatment of patients with advanced EGFR-mutant NSCLC
Author(s) -
Biagio Ricciuti,
Rita Chiari
Publication year - 2018
Publication title -
translational lung cancer research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.474
H-Index - 41
eISSN - 2226-4477
pISSN - 2218-6751
DOI - 10.21037/tlcr.2018.03.06
Subject(s) - osimertinib , medicine , mutant , oncology , t790m , cancer research , epidermal growth factor receptor , cancer , gene , genetics , erlotinib , gefitinib , biology